Tcrx Therapeutics Co.ltd

This early-stage study is testing a new, personalized cell therapy called KXV01 for people with advanced solid tumors that have not responded to standard treatments. The therapy involves collecting a patient's own immune cells, genetically modifying them to better target their sp…

This is a first-in-human study to test the safety and early signs of effectiveness of a new personalized gene therapy called KXV01 for people with advanced solid tumors. The therapy involves collecting a patient's own tumor cells, identifying unique markers, and then using a modi…